Naja Zoher M, Khatib Rania, Ziade Fouad M, Moussa Georges, Naja Zeina Z, Naja Ahmad Salah Eddine, Kanawati Saleh
Department of Anesthesia and Pain Management, Makassed General Hospital, Beirut, Lebanon.
Faculty of Public Health, Lebanese University, Beirut, Lebanon.
Saudi J Anaesth. 2014 Nov;8(Suppl 1):S57-62. doi: 10.4103/1658-354X.144078.
The use of opioids in surgeries for morbidly obese patients could cause respiratory depression. Therefore, alternative analgesics are needed to improve anesthetic management for obese patients. The objective of this study was to compare the effect of dexmedetomidine and clonidine on pain as well as analgesic consumption at 24 h postoperatively in patients undergoing laparoscopic gastric sleeve. The secondary objective was to compare patients' and surgeons' satisfaction.
A total of 60 obese and morbidly obese patients scheduled to undergo laparoscopic gastric sleeve were randomly assigned into two groups. 10 min after induction of general anesthesia, one group received 0.8-1.2 μg/kg/30 min intravenous (IV) clonidine through 500 mL lactated Ringer's solution and placebo (normal saline solution) through syringe pump. The second group received IV dexmedetomidine through syringe pump at a rate 0.5-0.8 μg/kg/h and placebo through 500 mL lactated Ringer's solution. Data on pain, analgesic consumption, and return to normal activity in addition to patients' and surgeons' satisfaction were collected.
Both groups were similar with respect to demographic and intraoperative hemodynamic characteristics. Fentanyl consumption, surgery duration and hospital stay were similar for the two groups. Pain scores on walking were significantly lower in the clonidine group at 12 h postoperatively (P = 0.014) compared with dexmedetomidine group. The number of patients who consumed pethidine was significantly lower in the clonidine group at 12 h postoperatively (P = 0.045).
This study concluded that clonidine and dexmedetomidine yielded similar outcomes with a difference in pain and analgesic consumption at 12 h postoperatively.
在病态肥胖患者的手术中使用阿片类药物可能会导致呼吸抑制。因此,需要替代镇痛药来改善肥胖患者的麻醉管理。本研究的目的是比较右美托咪定和可乐定对接受腹腔镜胃袖状切除术患者术后24小时疼痛及镇痛药消耗量的影响。次要目的是比较患者和外科医生的满意度。
总共60例计划接受腹腔镜胃袖状切除术的肥胖和病态肥胖患者被随机分为两组。全身麻醉诱导10分钟后,一组通过500 mL乳酸林格氏液以0.8 - 1.2 μg/kg/30分钟的速度静脉注射可乐定,并通过注射泵给予安慰剂(生理盐水溶液)。第二组通过注射泵以0.5 - 0.8 μg/kg/h的速度静脉注射右美托咪定,并通过500 mL乳酸林格氏液给予安慰剂。收集有关疼痛、镇痛药消耗量、恢复正常活动的数据以及患者和外科医生的满意度。
两组在人口统计学和术中血流动力学特征方面相似。两组的芬太尼消耗量、手术持续时间和住院时间相似。与右美托咪定组相比,可乐定组术后12小时行走时的疼痛评分显著更低(P = 0.014)。可乐定组术后12小时使用哌替啶的患者数量显著更低(P = 0.045)。
本研究得出结论,可乐定和右美托咪定产生了相似的结果,但术后12小时在疼痛和镇痛药消耗量方面存在差异。